Transthyretin (TTR) L55P Variant Monomers

CAT:
400-SPR-451C
Size:
2x 100 µg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: Yes
Transthyretin (TTR) L55P Variant Monomers - image 1

Transthyretin (TTR) L55P Variant Monomers

  • Background:

    Transthyretin is a transport protein in the serum and cerebospinal fluid that carried the thyroid hormone Thyroxine and retinol-binding protein bound to retinol. TTR misfolding and aggregation is known to be associated with the amyloiddiseases SSA, FAP and FAC (1-5) . TTR is also thought to have beneficial side effects, such as binding to beta-amyloid protein, preventing beta-amyloid from accumulating into the plaques associated with Alzheimer's Disease (6) . The L55P variant TTR is distinct from the other variants in that the L55P tetramer can dissociate to the monomeric amyloidogenic intermediate and form fibril precursors (7) .
  • Description:

    Human Recombinant Transthyretin (TTR) L55P Variant Monomers
  • Product Name Alternative:

    Amyloid polyneuropathy Protein Monomer, Amyloidosis I Protein Monomer, ATTR Protein Monomer, Carpal tunnel syndrome 1 Protein Monomer, CTS Protein Monomer, CTS1 Protein Monomer, = HEL111 Protein Monomer, HsT2651 Protein Monomer, PALB Protein Monomer, Prealbumin Protein Monomer, Prealbumin amyloidosis type I Protein Monomer, Prealbumin Thyroxine-binding Protein Monomer, TBPA Protein Monomer, Thyroxine binding prealbumin Protein Monomer, Transthyretin Protein Monomer, TTHY_HUMAN Protein Monomer, TTR Protein Monomer, TTR protein
  • UNSPSC:

    12352202
  • UN Code:

    Non-hazardous
  • Hazard Statement:

    Non-hazardous
  • Gene ID:

    7276
  • Swiss Prot:

    P02766
  • Accession Number:

    NP_000362.1
  • Cellular Locus:

    Cytoplasm | Extracellular exosome | Extracellular Region | Lysosome
  • Expression System:

    E. coli
  • Host:

    E. coli
  • Origin Species:

    Human
  • Target:

    Transthyretin (TTR)
  • Conjugation:

    No tag
  • Nature:

    Recombinant
  • Sequence:

    MGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGEPHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE
  • Applications:

    WB | SDS-PAGE | In vivo assay | In vitro assay
  • Field of Research:

    Neuroscience | Neurodegeneration | Alzheimer's Disease | ALS Disease | Tangles & Tau | Parkinson's Disease | Cardiovascular System | Blood | Cell Signaling | Metabolism | Lipid and lipoprotein Metabolism
  • Purification Method:

    Ion-exchange Purified
  • Purification:

    Ion-exchange Purified
  • Limit Of Detection:

    Certified >95% pure using SDS-PAGE analysis.
  • Concentration:

    Lot/batch specific. See included datasheet.
  • Purity:

    >95%
  • Weight:

    0.2
  • Length:

    Full length
  • Buffer:

    PBS pH 7.4
  • Molecular Weight:

    13.876 kDa
  • Precautions:

    Not for use in humans. Not for use in diagnostics or therapeutics. For research use only.
  • Additionnal Information:

    For corresponding PFFs, see catalog# SPR-464
  • References & Citations:

    1. Zeldenrust S.R., Benson M.D. (2010). Wiley. pp. 795–815. 2. Westermark P., Sletten K., Johansson B., Cornwell G.G. (1990). Proc. Natl. Acad. Sci. U.S.A. 87(7): 2843–5. 3. Andrade C. (1952). Brain. 75(3): 408–27. 4. Coelho T. (1996). Curr. Opin. Neurol. 9(5): 355–9. 5. Jacobson D.R, et. al. (1997). N. Engl. J. Med. 336(7): 466–73. 6. Li X. (2011). Mol Neurodegener. 6(1):79. 7. Lashuel H.A., Wurth C., Woo L., and Kelly J.W. (1999) Biochem. 38(41): 13560-13573.
  • Shipping Conditions:

    Dry Ice. Shipping note: Product will be shipped separately from other products purchased in the same order.
  • Storage Conditions:

    -80ºC
  • Notes:

    For corresponding PFFs, see catalog# SPR-464
  • Protein Length:

    Full length
  • Background Reference 01:

    1. Zeldenrust S.R., Benson M.D. (2010) . Wiley. pp. 795–815. 2. Westermark P., Sletten K., Johansson B., Cornwell G.G. (1990) . Proc. Natl. Acad. Sci. U.S.A. 87 (7) : 2843–5. 3. Andrade C. (1952) . Brain. 75 (3) : 408–27. 4. Coelho T. (1996) . Curr. Opin. Neurol. 9 (5) : 355–9. 5. Jacobson D.R, et. al. (1997) . N. Engl. J. Med. 336 (7) : 466–73. 6. Li X. (2011) . Mol Neurodegener. 6 (1) :79. 7. Lashuel H.A., Wurth C., Woo L., and Kelly J.W. (1999) Biochem. 38 (41) : 13560-13573.
  • Location:

    Cytoplasm | Extracellular exosome | Extracellular Region | Lysosome
  • AA Sequence:

    MGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGEPHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE
  • Immunogen Species:

    Human

MSDS

MSDS Document

View Document